Raymond James Starts Akebia Therapeutics (AKBA) at Outperform

August 13, 2018 4:28 PM EDT Send to a Friend
Raymond James analyst Reni Benjamin initiates coverage on Akebia ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login